Dr. Didi Ilole Mwengela, MD

Dr. Mwengela practices at Torrance Digestive Diseases & Gastroenterology in Torrance, California.

Dr. Mwengela's NPI, 1033479795, was assigned on May 29, 2012. Dr. Mwengela graduated from UC Irvine School of Medicine in 2012. Dr. Mwengela holds California license A128971.

Dr. Mwengela's primary practice is Torrance Digestive Diseases & Gastroenterology, at 2780 Skypark Drive, Suite 135, Torrance, CA 90505. The practice phone is (310) 530-8013.

Dr. Mwengela's primary practice is Torrance Digestive Diseases & Gastroenterology in Torrance, California. Dr. Mwengela is also affiliated with Torrance Memorial Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Mwengela to 1 more hospital, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mwengela practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mwengela's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Mwengela is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Mwengela's licenses on file in 2 states: California and New Mexico.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Mwengela treats.

CMS data shows 1,082 Medicare services from Dr. Mwengela across 12 procedure codes in 2024, for 398 Medicare patients. Medicare paid $89,962 for them.

CMS counts 398 Medicare patients who saw Dr. Mwengela in 2024. The largest group is 65 to 74, with 195 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mwengela's median patient age at 56, with 60% women.

In 2024, Dr. Mwengela wrote 486 Medicare Part D claims for 180 patients. 85% of them were for generic drugs. CMS names the drug for 386 of them, across 9 drugs with 11 or more claims each, at $64,983 in total drug cost. In 2023, CMS named 355 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Mwengela for performance year 2024, reported as part of a group. Dr. Mwengela accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mwengela as offering telehealth. CMS counts 52 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Mwengela, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Mwengela, published from 2017 to 2020. Dr. Mwengela's most frequent co-authors are Dino D. Beduya, James Leonard Buxbaum, MD and Ben Lin Da, MD.

CMS Open Payments shows 74 general payments to Dr. Mwengela from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $845.

Dr. Mwengela graduated from UC Irvine School of Medicine in 2012. Dr. Mwengela is a member of ACG, AGA and ASGE.

Dr. Mwengela is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.